Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $67,687 | 2 | 95.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,481 | 1 | 3.5% |
| Travel and Lodging | $295.00 | 1 | 0.4% |
| Food and Beverage | $119.90 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $67,424 | 2 | $0 (2022) |
| SANOFI PASTEUR INC. | $3,063 | 3 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $64.00 | 1 | $0 (2019) |
| Mirum Pharmaceuticals, Inc. | $24.23 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.77 | 3 | Mirum Pharmaceuticals, Inc. ($24.23) |
| 2022 | $70,168 | 3 | PFIZER INC. ($67,400) |
| 2019 | $64.00 | 1 | Merck Sharp & Dohme Corporation ($64.00) |
| 2018 | $319.13 | 2 | Sanofi Pasteur Inc. ($295.00) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Alagille syndrome | ||||||
| 01/17/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: ETONOGESTREL | ||||||
| 01/17/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: ETONOGESTREL | ||||||
| 04/14/2022 | SANOFI PASTEUR INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,480.50 | General |
| 04/04/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $67,400.00 | General |
| 02/20/2022 | SANOFI PASTEUR INC. | — | Consulting Fee | In-kind items and services | $287.41 | General |
| 10/28/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $64.00 | General |
| 06/21/2018 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $24.13 | General |
| 06/11/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $295.00 | General |
About Dr. Amy Middleman, MD
Dr. Amy Middleman, MD is a Adolescent Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063592475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Middleman, MD has received a total of $70,583 in payments from pharmaceutical and medical device companies, with $31.77 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($67,687).
Practice Information
- Specialty Adolescent Medicine
- Location Houston, TX
- Active Since 10/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080A0000X
- Entity Type Individual
- NPI Number 1063592475
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $295.00
- Livmarli (Drug) $24.23
- NEXPLANON (Drug) $7.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adolescent Medicine Doctors in Houston
Eugenie Kleinerman, M.d, M.D
Adolescent Medicine — Payments: $15,809
Joshua Samuels, M.d, M.D
Adolescent Medicine — Payments: $8,580
Michael Funke, M.d, M.D
Adolescent Medicine — Payments: $2,796
Dr. Renu Garg, Md, MD
Adolescent Medicine — Payments: $2,625
Dr. Shannon Hayes, M.d, M.D
Adolescent Medicine — Payments: $2,037
Cornelius Wilson, M.d, M.D
Adolescent Medicine — Payments: $1,302